2 not yet recruiting, 2 unknown, 1 completed, 1 recruiting. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Not yet recruiting 2, Unknown 2, Completed 1, Recruiting 1, Withdrawn 1 |
Follow Cervical Neoplasms: new trials by email Literature Review of Cervical Neoplasms trials Research Report on Cervical Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Cervical Cancer: A Single-arm Phase II Trial Adebrelimab - Cervical Neoplasms | Phase 2 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 35 | 2026-08-01 | 2026-07-28 |
| An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy Zanidatamab - Neoplasms, Solid Tumors | Phase 2 | Not yet recruiting | Haihua Yuan | 10 | 2026-06-15 | 2026-06-08 |
| Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor Trastuzumab Rezetecan - Solid Tumors, Neoplasms (Cancer / Tumors) | Phase 2 | Not yet recruiting | Haihua Yuan | 15 | 2026-06-15 | 2026-06-08 |
| Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors Cadonilimab, Nab paclitaxel - Uterine Cervical Neoplasms, Cancer of Cervix | Phase 2 | Unknown | Women's Hospital School Of Medicine Zhejiang University | 58 | 2023-06-01 | 2023-05-06 |
| Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer Sintilimab, quadrivalent HPV vaccine - Uterine Cervical Neoplasms, Cervical Cancer | Phase 2 | Unknown | Buhai Wang | 20 | 2019-07-31 | 2019-09-20 |
| Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients tri-weekly cisplatin - Cervical Neoplasms | Phase 2 | Withdrawn | Korea Cancer Center Hospital | 2009-01-01 | 2018-08-13 | |
| Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer CONCURRENT CHEMORADIATION (CISPLATIN) - CERVICAL NEOPLASMS | Phase 2 | Completed | Korea Cancer Center Hospital | 71 | 2006-03-01 | 2014-05-01 |
Uterine Cervical Neoplasms (7) · Carcinoma, Transitional Cell (2) · Colorectal Neoplasms (2) · Endometrial Neoplasms (2) · Head and Neck Neoplasms (2) · Neoplasms (2) · Pancreatic Neoplasms (2) · Biliary Tract Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Stomach Neoplasms (1)
Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Genital Neoplasms, Female (7) · Neoplasms by Site (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Uterine Cervical Diseases (7) · Uterine Diseases (7) · Uterine Neoplasms (7) · Neoplasms (5) · Carcinoma (2) · Colonic Diseases (2) · Digestive System Diseases (2)
Cisplatin (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Taxes (1) · sintilimab (1) · zanidatamab (1)
Haihua Yuan (2) · Korea Cancer Center Hospital (2) · Buhai Wang (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Women's Hospital School Of Medicine Zhejiang University (1)
China (2) · South Korea (2)
Buhai Wang (1) · Ge Lou, PHD (1) · Sang-Young Ryu, MD (1) · Yuechao Wu (1)
PMID 29095678, PMID 29787422, PMID 29967015, PMID 30826965, PMID 39608975